Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort.

Newschaffer CJ, Otani K, McDonald MK, Penberthy LT.

J Natl Cancer Inst. 2000 Apr 19;92(8):613-21.

PMID:
10772678
2.
3.

Cause of death in men diagnosed with prostate carcinoma.

Satariano WA, Ragland KE, Van Den Eeden SK.

Cancer. 1998 Sep 15;83(6):1180-8.

PMID:
9740084
4.

Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent.

Boulos DL, Groome PA, Brundage MD, Siemens DR, Mackillop WJ, Heaton JP, Schulze KM, Rohland SL.

Cancer. 2006 Apr 15;106(8):1804-14.

5.

Re: Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort.

Romano PS.

J Natl Cancer Inst. 2001 Mar 7;93(5):397-8. No abstract available.

PMID:
11238704
6.

Primary causes of death after permanent prostate brachytherapy.

Bittner N, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Allen ZA, Brammer SG, Moyad M.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):433-40. doi: 10.1016/j.ijrobp.2008.02.013. Epub 2008 Apr 28.

PMID:
18448268
7.

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer.

D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW.

Cancer. 2008 Dec 15;113(12):3290-7. doi: 10.1002/cncr.23970.

8.

Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.

Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM.

Am J Med. 2006 May;119(5):418-25.

PMID:
16651054
9.

Long-term survival in a Swedish population-based cohort of men with prostate cancer.

Sandblom G, Dufmats M, Varenhorst E.

Urology. 2000 Sep 1;56(3):442-7.

PMID:
10962312
11.

High prostate cancer mortality in Norway evaluated by automated classification of medical entities.

Hernes E, Johansson LA, Fosså SD, Pedersen AG, Glattre E.

Eur J Cancer Prev. 2008 Aug;17(4):331-5. doi: 10.1097/CEJ.0b013e3282f5220d.

PMID:
18562957
12.

Pretreatment predictors of time to cancer specific death after prostate specific antigen failure.

D'Amico AV, Cote K, Loffredo M, Renshaw AA, Chen MH.

J Urol. 2003 Apr;169(4):1320-4.

PMID:
12629352
13.

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson JE; Scandinavian Prostate Cancer Group Study Number 4.

J Natl Cancer Inst. 2008 Aug 20;100(16):1144-54. doi: 10.1093/jnci/djn255. Epub 2008 Aug 11.

14.
15.

Short- and long-term mortality with localized prostate cancer.

Merglen A, Schmidlin F, Fioretta G, Verkooijen HM, Rapiti E, Zanetti R, Miralbell R, Bouchardy C.

Arch Intern Med. 2007 Oct 8;167(18):1944-50.

PMID:
17923593
16.
17.

Reliability of death certificates in prostate cancer patients.

Fall K, Strömberg F, Rosell J, Andrèn O, Varenhorst E; South-East Region Prostate Cancer Group.

Scand J Urol Nephrol. 2008;42(4):352-7. doi: 10.1080/00365590802078583.

PMID:
18609293
18.

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.

Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S.

Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23.

PMID:
18783735
19.

When to diagnose and how to treat prostate cancer in the "not too fit" elderly.

Dahm P, Silverstein AD, Weizer AZ, Crisci A, Vieweg J, Paulson DF.

Crit Rev Oncol Hematol. 2003 Nov;48(2):123-31.

PMID:
14607375
20.

Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates.

Groome PA, Rohland SL, Siemens DR, Brundage MD, Heaton J, Mackillop WJ.

Cancer. 2011 Sep 1;117(17):3943-52. doi: 10.1002/cncr.25984. Epub 2011 Feb 24.

Supplemental Content

Support Center